4//SEC Filing
Ledo Capital, LLC 4
Accession 0000899243-20-032258
CIK 0001274792other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:05 PM ET
Size
17.9 KB
Accession
0000899243-20-032258
Insider Transaction Report
Form 4
Ledo Capital, LLC
Other
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote)
NEWTYN PARTNERS, LP
Other
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote)
Levy Noah G.
DirectorOther
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares are directly held by NP. The general partner of the Funds is NCP. The general partner of NCP is Ledo. The investment manager to the Funds is Newtyn Management. The managing member of Newtyn Management and Ledo and the portfolio manager to the Funds is Mr. Levy. Each of Newtyn Management, Ledo, NCP and Mr. Levy disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F2]The shares are directly held Newtyn TE. The general partner of the Funds is NCP. The general partner of NCP is Ledo. The investment manager to the Funds is Newtyn Management. The managing member of Newtyn Management and Ledo and the portfolio manager to the Funds is Mr. Levy. Each of Newtyn Management, Ledo, NCP and Mr. Levy disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001789647
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 4:05 PM ET
- Size
- 17.9 KB